To evaluate the antiretroviral activity of antiretroviral agents and to compare the effects of two different antiretroviral agents, we propose a non-parametric mixed-effects model to investigate change of CD4+ counts. The proposed model and methods are applied to analyse the data from PACTG345 study. Population and individual patterns of change of CD4+ counts and a reference band are obtained. Our results indicate that treatment with high-dose ritonavir is significantly superior compared with low-dose ritonavir.
Get full access to this article
View all access options for this article.
References
1.
Feinberg MB, Kaplan JEReport of the NIH panel to define principles of therapy of HIV infection. Supplement to Morbidity and Mortality Weekly Report 47 (RR-5), US Department of Health and Human Services, Center for Disease Control and Prevention (CDC), Atlanta, Georgia. 1999.
2.
Stanley SK, Kaplan JE, National Center for HIV, STD, and TB Prevention Division of HIV/AIDS Prevention Surveillance, and EpidemiologyGuidelines for the use of antiretroviral agents in HIV-infected adults and adolescents Supplement to Morbidity and Mortality Weekly Report 47 (RR-5) , US Department of Health and Human Services, Center for Disease Control and Prevention (CDC), Atlanta, Georgia. 1998.
3.
Gottlieb GS, Nickle DC, Jensen MA, Wong KG, Grobler J., Li F., Liu SL, Rademeyer C., Learn GH, Karim SSA, Williamson C., Corey L., Margolick JB, Mullins JIDual HIV-1 infection associated with rapid disease progression. The Lancet2004; 363: 619-22.
4.
Taylor JM, Kim DKMarker values at the time of an AIDS diagnosis. Statistics in Medicine1994; 13: 2059-66.
5.
Pezzotti P., Galai N., Vlahov D., Rezza G., Lyles CM, Astemborski J.Direct comparison of time to AIDS and infectious disease death between HIV seroconverter injection drug users in Italy and the United States: results from the ALIVE and ISS studies. JAIDS1999 ; 20: 275-82.
6.
Ullum H., Lepri AC, Aladdin H., Katzenstein T., Victor J., Phillips AN, Gerstoft J., Skinhoj P., Pedersen BKNatural immunity and HIV disease progression. AIDS1999; 13: 557-63.
7.
Tsiatis AA, DeGruttola V., Wulfsohn MSModeling the relationship of survival to longitudinal data measured with error. Applications to survival and CD4+ counts in patients with AIDS . Journal of the American Statistical Association1995; 90: 27-37.
8.
Henderson R. , Diggle P., Dobson A.Joint modelling of longitudinal measurements and event time data. Biostatistics2000; 1: 465-80.
9.
Thiébaut R., Jacqmin-Gadda H., Babiker A., Commenges D., The CASCADE Collaboration.Joint modelling of bivariate longitudinal data with informative dropout and left-censoring, with application to the evolution of CD4+ cell count and HIV RNA viral load in response to treatment of HIV infection. Statistics in Medicine2005; 24: 65-82.
10.
HIV Surrogate Marker Collaboration.Human immunodeficiency virus type 1 RNA level and CD4+ count as prognostic markers and surrogate end points: a meta-analysis. AIDS Research and Human Retroviruses2000; 16: 1123-33.
11.
Dromer F., Mathoulin-Pélissier S., Fontante A., Ronin O., Dupont B., Lortholary O., French Cryptococcosis Study Group.Epidemiology of HIV-associated cryptococcosis in France (1985-2001): comparison of the pre- and post- HAART eras. AIDS2004; 18: 555-62.
12.
Benson CA, van der Horst C., LaMarca A., Haas DW, McDonald CK, Steinhart CR, Rublein J., Quinn JB, Mondou E., Rousseau F.A randomized study of emtricitabine and lamivudine in stably suppressed patients with HIV. AIDS2004; 18: 2269-76.
13.
DeSimone JA , Pomerantz RJ, Babinchak TJInflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Annals of Internal Medicine2000 ; 133: 447-54.
14.
Scott ZA, Chadwick EG, Gibson LL, Catalina MD, McManus MM, Yogev R., Palumbo P., Sullivan JL, Britto P., Gay H., Luzuriaga K., PACTG(Pediatric AIDS Clinical Trial Group) 345 Investigators.Infrequent detection of HIV-1-specific, but not cytomegalovirus-specific, CD8+T cell responses in young HIV-1-infected infants. Journal of Immunology2001; 167: 7134-40.
15.
Chadwick EG, Palumbo P., Rodman J., Luzuriaga K., Britto P.Early therapy with ritonavir (RTV), ZDV and 3TC in HIV-1 infected children 1-24 months of age. The 8th conference on retroviruses and opportunistic infections, Chicago, IL, February 2001.
16.
Shi MG, Weiss RE, Taylor JMG.An analysis of pediatric CD4 counts for acquired immune deficiency syndrome using flexible random curves. Applied Statistics1996; 45: 151-63.
Taylor JMG , Cumberland WG, Sy JPA stochastic model for analysis of longitudinal AIDS data. Journal of the American Statistical Association1994; 89: 727-36.
19.
Fan JQ, Gijbels I.Local polynomial modelling and its applications. Chapman and Hall, 1996.
20.
Wu HL, Zhang JTLocal polynomial mixed-effects models for longitudinal data. Journal of the American Statistical Association2002 ; 97: 883-97.
21.
Wu HL, Zhang JTNon-parametric regression methods for longitudinal data analysis. John Wiley & Sons, 2006.
22.
Wu HL, Liang H.Backfitting random varying-coefficient models with time-dependent smoothing covariates. Scandinavian Journal of Statistics2004; 31: 3-19.
23.
Davidian M., Giltinan DMNonlinear models for repeated measurement data. Chapman & Hall, 1995.
24.
Young SG, Bowman AWNon-parametric analysis of covariance. Biometrics1995; 51: 920-31.
25.
Pinheiro JC, Bates DMMixed-effects models in S and S-PLUS. Springer , 2000.
